• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·002258.SZ
Share

Lier Chemical Co.,LTD. Stocks

CN¥ 13.9Last Updated 13.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.59B

CN¥ 13.9
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1993 and based in Mianyang, China, Lier Chemical Co.,LTD. functions as a comprehensive entity focused on the research, development, manufacturing, and worldwide distribution of agrochemical products. The company's diverse product line encompasses a selection of low-toxicity and low-residue pesticides, including prominent examples such as chloropyridines and organophosphates. Its extensive offerings for crop protection also feature numerous herbicides, specifically pinoxaden, glufosinate-ammonium, diquat, flumioxazin, clodinafop-propargyl, clopyralid acid, picloram, fluroxypyr-meptyl, triclopyr, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac. Additionally, Lier Chemical provides fungicides like azoxystrobin, epoxiconazole, iprodione, and difenoconazole, alongside insecticides such as chlorpyrifos and pyriproxyfen. Beyond its agricultural chemical focus, the company produces active pharmaceutical ingredients (APIs) and their respective formulations. A substantial part of its business involves the synthesis of a broad spectrum of chemical intermediates, most notably pyridine derivatives including 2-chloropyridine, 2,3-dichloropyridine, 2,5-dichloropyridine, 2,6-dichloropyridine, 2,3,4-trichloropyridine, 2,3,5-trichloropyridine, 2,3,6-trichloropyridine, nitrapyrin, pentafluoropyridine, 2,3,5,6-tetrachloro-4-methylsulfonylpyridine, 6-chloropyridine-2-carbonitrile, 3,6-difluoropyridine-2-carboxylic acid, 2,2'-bipyridine, 2-chloro-4'-fluoroacetophenone, 2-chloro-2',4'-difluoroacetophenone, and 2-fluoro-3-nitrobenzoic acid. Other specialized intermediates manufactured include (E)-4-(dimethylamino)but-2-enoic acid hydrochloride, 4,4'-dichloro-[3,3']bipyridinyl, clopyralid-methyl, methyl 3,4,6-trichloropicolinate, 2,4,5-trichloropyridine, 7-fluoro-6-nitro-4-hydroxyquinazoline, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, 4-bromocrotonic acid, 4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine, 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide, and 5-chloro-8-hydroxyquinoline.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, undervalu

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of 002258.SZ is 15.0 and suggests 11.7% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.07.2026 16:55

Morgan Stanley Expects Earnings Growth Outside the Tech Sector. What to Buy Ahead of Earnings Season?

13.07.2026 16:34

Oninvest Index: Top AI Small-Caps for the First Half of the Year

13.07.2026 15:34

Morning in New York: External Factors Heighten Risks

13.07.2026 14:37

Shares of L’Oréal’s small-cap partner have surged. It will go private

13.07.2026 13:45

SK Hynix Shares Have Their Worst Day Ever After a Record-Breaking U.S. Debut. Is It Time to Buy?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026